Your browser doesn't support javascript.
loading
Long-Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo-Controlled Observation in the ODYSSEY OUTCOMES Trial.
Goodman, Shaun G; Steg, Philippe Gabriel; Poulouin, Yann; Bhatt, Deepak L; Bittner, Vera A; Diaz, Rafael; Garon, Genevieve; Harrington, Robert A; Jukema, J Wouter; Manvelian, Garen; Stipek, Wanda; Szarek, Michael; White, Harvey D; Schwartz, Gregory G.
Afiliación
  • Goodman SG; Canadian VIGOUR Centre University of Alberta Alberta Edmonton Canada.
  • Steg PG; St. Michael's Hospital, Unity Health Toronto, University of Toronto Ontario Toronto Canada.
  • Poulouin Y; Université Paris-Cité, INSERM (Institut National de la Santé Et de la Recherche Médicale) U1148, and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Paris France.
  • Bhatt DL; FACT (French Alliance for Cardiovascular Trials), Institut Universitaire de France Paris France.
  • Bittner VA; IT&M Stats Neuilly-sur-Seine France.
  • Diaz R; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai NY New York USA.
  • Garon G; Division of Cardiovascular Disease University of Alabama at Birmingham AL Birmingham USA.
  • Harrington RA; Estudios Cardiológicos Latinoamérica Instituto Cardiovascular de Rosario Rosario Argentina.
  • Jukema JW; Sanofi Quebec Montreal Canada.
  • Manvelian G; Stanford Center for Clinical Research, Department of Medicine Stanford University CA Stanford USA.
  • Stipek W; Department of Cardiology Leiden University Medical Center Leiden the Netherlands.
  • Szarek M; Netherlands Heart Institute Utrecht the Netherlands.
  • White HD; Regeneron Pharmaceuticals NY Tarrytown USA.
  • Schwartz GG; Sanofi NJ Bridgewater USA.
J Am Heart Assoc ; 12(18): e029216, 2023 09 19.
Article en En | MEDLINE | ID: mdl-37702079
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Am Heart Assoc Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Am Heart Assoc Año: 2023 Tipo del documento: Article